"What is news is who is showing up to fill the gap." And folks, that is the kickoff return in Gorrindo, Livesey, and Torous's new JAMA Psychiatry viewpoint: behavioral health care has a supply problem, demand is sprinting downfield, and AI tools have wandered onto the field wearing shoulder pads.
The paper is not saying, "Congrats, chatbot, you are now a psychiatrist." Nobody sane wants the mascot calling plays in the fourth quarter. The argument is subtler and more interesting: CMS's new ACCESS payment model could make AI-delivered behavioral health care financially viable inside Medicare, not just as a cash-pay app lurking in the App Store like a protein bar with a privacy policy.
The Play: Pay for Outcomes, Not Button-Mashing
CMS's ACCESS model, short for Advancing Chronic Care with Effective, Scalable Solutions, starts in July 2026 as a voluntary 10-year Medicare model. It tests "Outcome-Aligned Payments," meaning organizations get predictable payments for managing conditions and earn the full amount when patients hit measurable goals. The behavioral health track includes depression and anxiety, the two opponents that have been blitzing the health system for years.
That matters because traditional fee-for-service medicine pays for visits, codes, and billable activities. It is basically a scoreboard that says, "Nice job running many plays," even if nobody moved the ball. ACCESS tries to reward health improvement instead. If AI tools can help patients between visits, monitor symptoms, support behavioral activation, flag deterioration, or route someone to a clinician when needed, this model may finally give those tools a payment lane.
That is the policy equivalent of opening a hole in the offensive line.
Why AI Is Even in This Game
The brutal backdrop: behavioral health demand keeps climbing while clinicians remain scarce. Gorrindo and colleagues note that consumer-facing mental health tech and general-purpose generative AI are already becoming a "front door" for support, sometimes intentionally and sometimes because users ask ChatGPT about panic attacks at 1:13 a.m. because the human system closed at five.
Research is moving fast. A 2025 systematic review and meta-analysis in JMIR found that generative AI mental health chatbots showed a small average benefit across 14 randomized trials, while also stressing the risk pile sitting on the sideline with a clipboard. A 2026 scoping review in Frontiers in Psychiatry found the evidence still clusters around depression and anxiety, with limited external validation and short follow-up. Translation: promising, but the trophy case is not full yet.
And the safety tape is not decorative. Recent work on AI psychotherapy risk taxonomies argues that mental health chatbots need evaluation methods that catch subtle harms across a conversation, not just whether the bot says something nice in a single screenshot. A chatbot that validates a delusion with golden-retriever enthusiasm is not "empathetic." It is fumbling on its own 2-yard line.
The Real Contest: Access vs. Accountability
ACCESS could push the market toward tools that prove they help. That is the upside. If organizations only get fully paid when patients improve on validated measures, AI vendors may need more than a shiny demo and the phrase "clinically informed," which currently does a lot of stretching.
But outcome-based payment also creates new ways to be clever in bad ways. Who gets enrolled? Which outcomes count? How do we risk-adjust so providers do not avoid patients with complex needs? How do we make sure the AI escalates crisis risk instead of offering breathing exercises while the house is on fire?
This is where boring infrastructure becomes the MVP. Validated measures, audit trails, privacy, FDA rules where relevant, clinician oversight, and transparent reporting all matter. Even something as humble as comparing CMS PDFs and policy documents matters here - tools like pdfb2.io are useful precisely because health policy often arrives as a paperwork avalanche wearing a necktie.
The Buzzer-Beater Potential
If ACCESS works, AI-supported behavioral health could become less like a wellness subscription and more like a monitored care model: human clinicians, software support, measurement, escalation, and payment tied to patient progress. That could help people who cannot get timely therapy, live far from specialists, or need support between appointments.
But the win condition is not "more AI." The win condition is better care. AI should be the assistant coach with a tablet, not the entire franchise. It can help track patterns, suggest next steps, keep patients engaged, and reduce administrative drag. It should not pretend to replace the clinical judgment, relationship, and accountability that actual care requires.
So here comes CMS, stepping onto the field with a payment model that may decide whether AI behavioral health tools become a serious part of care or just another sideline gadget. The clock is running. The crowd is nervous. The overworked clinicians are looking at the bench.
And AI, apparently, has been warming up.
References
-
Gorrindo T, Livesey C, Torous J. "A New CMS Payment Model for AI-Delivered Behavioral Health Care." JAMA Psychiatry. Published online June 24, 2026. DOI: 10.1001/jamapsychiatry.2026.1681
-
Centers for Medicare & Medicaid Services. "Improving ACCESS to Technology-Supported Care with Outcome-Aligned Payments." CMS, December 19, 2025. CMS ACCESS Model overview
-
Zhang Q, Zhang R, Xiong Y, Sui Y, Tong C, Lin FH. "Generative AI Mental Health Chatbots as Therapeutic Tools: Systematic Review and Meta-Analysis of Their Role in Reducing Mental Health Issues." Journal of Medical Internet Research. 2025;27:e78238. DOI: 10.2196/78238. PMCID: PMC12707440
-
Abu-Mahfouz MS, AlFehaid S, Burqan HM, El Arab RA. "Artificial intelligence in mental health care: a scoping review of reviews." Frontiers in Psychiatry. 2026;17. DOI: 10.3389/fpsyt.2026.1688043
-
Steenstra I, Bickmore TW. "A Risk Taxonomy for Evaluating AI-Powered Psychotherapy Agents." arXiv: 2505.15108, 2025.
Disclaimer: This blog post is a simplified summary of published research for educational purposes. The accompanying illustration is artistic and does not depict actual model architectures, data, or experimental results. Always refer to the original paper for technical details.